Related Experiment Video
Updated: Mar 11, 2026

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Published on: October 3, 2012
Isolation of a Defective Prion Mutant from Natural Scrapie
Ilaria Vanni1, Sergio Migliore2, Gian Mario Cosseddu3
1Department of Veterinary Public Health and Food Safety, Istituto Superiore di Sanità, Rome, Italy.
Abstract:
It is widely known that prion strains can mutate in response to modification of the replication environment and we have recently reported that prion mutations can occur in vitro during amplification of vole-adapted prions by Protein Misfolding Cyclic Amplification on bank vole substrate (bvPMCA). Here we exploited the high efficiency of prion replication by bvPMCA to study the in vitro propagation of natural scrapie isolates. Although in vitro vole-adapted PrPSc conformers were usually similar to the sheep counterpart, we repeatedly isolated a PrPSc mutant exclusively when starting from extremely diluted seeds of a single sheep isolate. The mutant and faithful PrPSc conformers showed to be efficiently autocatalytic in vitro and were characterized by different PrP protease resistant cores, spanning aa ∼155-231 and ∼80-231 respectively, and by different conformational stabilities. The two conformers could thus be seen as different bona fide PrPSc types, putatively accounting for prion populations with different biological properties. Indeed, once inoculated in bank vole the faithful conformer was competent for in vivo replication while the mutant was unable to infect voles, de facto behaving like a defective prion mutant. Overall, our findings confirm that prions can adapt and evolve in the new replication environments and that the starting population size can affect their evolutionary landscape, at least in vitro. Furthermore, we report the first example of "authentic" defective prion mutant, composed of brain-derived PrPC and originating from a natural scrapie isolate. Our results clearly indicate that the defective mutant lacks of some structural characteristics, that presumably involve the central region ∼90-155, critical for infectivity but not for in vitro replication. Finally, we propose a molecular mechanism able to account for the discordant in vitro and in vivo behavior, suggesting possible new paths for investigating the molecular bases of prion infectivity.
Insights
Prion strains can mutate in vitro, leading to defective mutants that replicate but do not infect. Starting prion concentration influences this evolution, revealing insights into prion infectivity mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Prion Biology
Background:
- Prion strains are known to mutate based on their replication environment.
- In vitro prion mutation during amplification has been previously reported.
Purpose of the Study:
- To investigate the in vitro propagation of natural scrapie isolates using Protein Misfolding Cyclic Amplification (PMCA).
- To characterize prion mutants arising from diluted natural scrapie seeds.
- To understand the factors influencing prion evolution and infectivity.
Main Methods:
- Utilized bank vole-derived Protein Misfolding Cyclic Amplification (bvPMCA) for efficient prion replication.
- Studied natural scrapie isolates, focusing on extremely diluted seeds.
- Characterized PrPSc conformers by protease-resistant core size and conformational stability.
- Inoculated resulting conformers into bank voles to assess in vivo infectivity.
Main Results:
- A distinct PrPSc mutant was repeatedly isolated from a diluted sheep scrapie isolate in vitro.
- The mutant and faithful PrPSc conformers exhibited different protease-resistant cores (aa ~155-231 vs. ~80-231) and stabilities.
- The faithful conformer replicated in vivo, while the mutant was non-infectious in bank voles.
- The defective mutant appears to lack structural elements in the central region (~90-155) crucial for infectivity.
Conclusions:
- Prions can adapt and evolve in vitro, with starting population size influencing this evolutionary landscape.
- The study reports the first authentic defective prion mutant from a natural scrapie isolate.
- A molecular mechanism for discordant in vitro and in vivo prion behavior is proposed, highlighting key regions for infectivity.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Subviral Agents

